Prognostic effect of tumor location in stage II and III colon cancer.

被引：0
|
作者：
Ozveren, Ahmet
Surmeli, Zeki Gokhan
Turgut, Asli
Karaca, Burcak
Karabulut, Bulent
Sanli, Ulus Ali
Uslu, Ruchan
机构：
[1] Ege Univ, Sch Med, Div Med Oncol, Izmir, Turkey
[2] Ege Univ, Sch Med, Izmir, Turkey
[3] Ege Univ, Izmir, Turkey
[4] Ege Univ, Tulay Aktas Oncol Hosp, Sch Med, Izmir, Turkey
[5] Ege Univ, Tulay Aktas Oncol Hosp, Sch Med, Bornova, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14652
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14652
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
    Dalerba, Piero
    Sahoo, Debashis
    Paik, Soonmyung
    Guo, Xiangqian
    Yothers, Greg
    Song, Nan
    Wilcox-Fogel, Nate
    Forgo, Erna
    Rajendran, Pradeep S.
    Miranda, Stephen P.
    Hisamori, Shigeo
    Hutchison, Jacqueline
    Kalisky, Tomer
    Qian, Dalong
    Wolmark, Norman
    Fisher, George A.
    van de Rijn, Matt
    Clarke, Michael F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 211 - 222
  • [22] Tumor purity as a prognostic factor in colon cancer.
    Xu, Jianmin
    Mao, Yihao
    Feng, Qingyang
    Zheng, Peng
    Yang, Liangliang
    Zhu, Dexiang
    Chang, Wenju
    Ji, Meiling
    Ren, Li
    Wei, Ye
    He, Guodong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Association of genetic variants in obesity-related genes with tumor recurrence in stage II/III colon cancer.
    Ladner, Robert D.
    Gerger, Armin
    Zhang, Wu
    Labonte, Melissa Janae
    Yang, Dongyun
    Lenz, Felicitas
    Lenz, Cosima
    Bohanes, Pierre Oliver
    Ning, Yan
    Winder, Thomas
    Wilson, Peter M. D.
    Benhaim, Leonor
    El-Khoueiry, Rita
    El-Khoueiry, Anthony B.
    Iqbal, Syma
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Beyond Primary Tumor Location and RAS/BRAF Mutational Status as Prognostic Factor in Stage III Colon Cancer Reply
    Taieb, Julien
    JAMA ONCOLOGY, 2018, 4 (09) : 1298 - 1298
  • [25] Association of prognostic value of primary tumor location in stage III colon cancer with RAS and BRAF mutational status.
    Taieb, Julien
    Kourie, Ham Pig Raphael
    Emile, Jean-Francois
    Le Malicot, Karine
    Balogoun, Ralyath
    Tabernero, Josep
    Mini, Enrico
    Folprecht, Gunnar
    Van Laethenn, Jean-Luc
    Mulot, Claire
    Bouche, Olivier
    Aparicio, Thomas
    Michel, Pierre
    Thaler, Josef
    Bridgewater, John A.
    Van Cutsem, Eric
    Perkins, Geraldine
    Salazar, Ramon
    Lepage, Come
    Laurent-Puig, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Prognostic value of primary tumor location in stage III colon cancer is associated with RAS and BRAF mutational status.
    Julien, Taieb
    Raphael, Kourie Hampig
    Francois, Emile Jean
    Karine, Le Malicot
    Ralyath, Balogoun
    Josep, Tabernero
    Enrico, Mini
    Gunnar, Folprecht
    Luc, Van Laethem Jean
    Claire, Mulot
    Olivier, Bouche
    Thomas, Aparicio
    Pierre, Michel
    Josef, Thaler
    John, Bridgewater
    Eric, Van Cutsem
    Geraldine, Perkins
    Come, Lepage
    Ramon, Salazar
    Pierre, Laurent Puig
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer.
    Lo, D. S.
    Pollett, A.
    Gallinger, S.
    Siu, L. L.
    Burkes, R. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 162S - 162S
  • [28] Prognostic relevance of primary tumor location in stage III and II colon cancer: Experience at University Hospital Ramon y Cajal (HURyC) Madrid.
    Garcia, Arantzazu Martinez Barquin
    Saez, Olga Martinez
    Domingo, Juan Jose Serrano
    Huertas, Roberto Martin
    Delgado, Maria Villamayor
    Serrano, Cristina Saavedra
    de la Fuente, Elena Corral
    Puertas, Pablo Reguera
    Longo, Federico
    Olmos, Vanesa Pachon
    Garrote, Mercedes Rodriguez
    Guillen, Carmen
    Carrato, Alfredo
    Ferreiro, Reyes
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [29] Evaluating the Prognostic Significance of Lymphovascular Invasion in Stage II and III Colon Cancer
    Mutabdzic, D.
    O'Brien, S. B.
    Handorf, E.
    Devarajan, K.
    Reddy, S.
    Sigurdson, E. R.
    Denlinger, C.
    Meyer, J. E.
    Farma, J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S110 - S110
  • [30] Prognostic relevance of Src activation in stage II-III colon cancer
    Martinez-Perez, Julia
    Lopez-Calderero, Iker
    Saez, Carmen
    Benavent, Marta
    Limon, Maria L.
    Gonzalez-Exposito, Reyes
    Soldevilla, Beatriz
    Carmen Riesco-Martinez, Maria
    Salamanca, Javier
    Carnero, Amancio
    Garcia-Carbonero, Rocio
    HUMAN PATHOLOGY, 2017, 67 : 119 - 125
12345